Biomanufacturing
Domestic biomanufacturing. Vertically integrated. Operating in alignment with applicable regulatory requirements.
Velocity Bioworks is Valion Bio’s wholly owned contract development and manufacturing organization (CDMO) — a U.S.-based biomanufacturing facility that supports Valion Bio’s own supply chain and generates independent commercial revenue serving outside clinical-stage biotech clients.
Why it Matters
Most clinical-stage biotech companies depend on third-party manufacturers — a structural consideration in timelines, costs, and supply chain resilience. Velocity Bioworks supports Valion Bio’s own pipeline and operates as a revenue-generating strategic asset.
For federally funded biodefense programs and engagement with federal biodefense agencies, domestic biomanufacturing operating in alignment with applicable regulatory requirements is an important capability. Velocity was built with that standard in mind.
What Velocity Does
Velocity Bioworks operates from San Antonio, Texas, and provides end-to-end support for clinical-stage biologics development and manufacturing, including:
- cGMP drug substance and cell bank manufacturing.
- Upstream and downstream process development and optimization.
- Analytical testing, assay development, and qualification.
- Quality control and stability testing.
- Microbial expression systems.
- Technology transfer and program management.
- Regulatory compliance support.
Built for speed to clinic
Velocity is structured around a single operating principle: translate defined program goals into scalable manufacturing processes and robust analytical strategies without compromising quality or timeline. The team designs programs to support near-term clinical milestones while meeting every applicable quality and regulatory requirement.
By the Numbers
200x
Manufacturing scale-up achieved — from research to commercial-grade production volumes.
~1.3 million
Human-equivalent doses produced under the scaled-up process.
$50M+
Revenue-generating capacity available from the San Antonio facility, expandable with future investment.
Partner with Velocity Bioworks
Velocity serves clinical-stage biotech clients outside the Valion Bio portfolio. If your program requires cGMP manufacturing, process development, or analytical services from a U.S.-based, government-compliant facility, our team is ready to discuss the fit.